Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: A randomized controlled trial Academic Article uri icon

Overview

MeSH Major

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Carbazoles
  • Diabetes Mellitus, Type 2
  • Hemoglobin A, Glycosylated
  • Hypertension
  • Metoprolol
  • Propanolamines

abstract

  • Both beta-blockers were well tolerated; use of carvedilol in the presence of RAS blockade did not affect glycemic control and improved some components of the metabolic syndrome relative to metoprolol in participants with DM and hypertension. The effects of the 2 beta-blockers on clinical outcomes need to be compared in long-term clinical trials.

publication date

  • November 10, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jama.292.18.2227

PubMed ID

  • 15536109

Additional Document Info

start page

  • 2227

end page

  • 36

volume

  • 292

number

  • 18